LY503430, a Novel α-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Potentiator with Functional, Neuroprotective and Neurotrophic Effects in Rodent Models of Parkinson's Disease

Tracey K. Murray; Katherine Whalley; Christine S. Robinson; Mark A. Ward; Caroline A. Hicks; David Lodge; Jim L. Vandergriff; Polly Baumbarger; Edward Siuda; Mary Gates; Ann M. Ogden; Phil Skolnick; Dennis M. Zimmerman; Eric S. Nisenbaum; David Bleakman; Michael J. O'Neill

doi:10.1124/jpet.103.049445

Research ArticleNEUROPHARMACOLOGY

LY503430, a Novel α-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Potentiator with Functional, Neuroprotective and Neurotrophic Effects in Rodent Models of Parkinson's Disease

Tracey K. Murray, Katherine Whalley, Christine S. Robinson, Mark A. Ward, Caroline A. Hicks, David Lodge, Jim L. Vandergriff, Polly Baumbarger, Edward Siuda, Mary Gates, Ann M. Ogden, Phil Skolnick, Dennis M. Zimmerman, Eric S. Nisenbaum, David Bleakman and Michael J. O'Neill

Journal of Pharmacology and Experimental Therapeutics August 2003, 306 (2) 752-762; DOI: https://doi.org/10.1124/jpet.103.049445

Tracey K. Murray

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Katherine Whalley

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christine S. Robinson

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mark A. Ward

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Caroline A. Hicks

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

David Lodge

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jim L. Vandergriff

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Polly Baumbarger

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Edward Siuda

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mary Gates

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ann M. Ogden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Phil Skolnick

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Dennis M. Zimmerman

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Eric S. Nisenbaum

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

David Bleakman

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael J. O'Neill

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
eLetters
PDF

Submit a Response to This Article

Compose eLetter

Title *

Contents

More information about text formats

Plain text

No HTML tags allowed.
Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

Author Information

Contributors
First Name and Middle Initial * First or given name, e.g. 'Peter'. Last Name * Your last, or family, name, e.g. 'MacMoody'. Email Address * Your email address, e.g. higgs-boson@gmail.com Occupation * Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation * Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests? *

Yes

Please describe the competing interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.

PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics

Vol. 306, Issue 2

1 Aug 2003

Table of Contents
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following LY503430, a Novel α-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Potentiator with Functional, Neuroprotective and Neurotrophic Effects in Rodent Models of Parkinson's Disease

Message Subject (Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics

Message Body (Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Research ArticleNEUROPHARMACOLOGY

LY503430, a Novel α-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Potentiator with Functional, Neuroprotective and Neurotrophic Effects in Rodent Models of Parkinson's Disease

Journal of Pharmacology and Experimental Therapeutics August 1, 2003, 306 (2) 752-762; DOI: https://doi.org/10.1124/jpet.103.049445

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Research ArticleNEUROPHARMACOLOGY

LY503430, a Novel α-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Potentiator with Functional, Neuroprotective and Neurotrophic Effects in Rodent Models of Parkinson's Disease

Journal of Pharmacology and Experimental Therapeutics August 1, 2003, 306 (2) 752-762; DOI: https://doi.org/10.1124/jpet.103.049445

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
eLetters
PDF

Main menu

User menu

Search

LY503430, a Novel α-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Potentiator with Functional, Neuroprotective and Neurotrophic Effects in Rodent Models of Parkinson's Disease

Plain text

Vertical Tabs

Jump to comment:

In this issue

LY503430, a Novel α-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Potentiator with Functional, Neuroprotective and Neurotrophic Effects in Rodent Models of Parkinson's Disease

Citation Manager Formats

LY503430, a Novel α-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Potentiator with Functional, Neuroprotective and Neurotrophic Effects in Rodent Models of Parkinson's Disease

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Navigate

More Information

ASPET's Other Journals